Earnings Feed
Start Free
Amneal Pharmaceuticals, Inc.·4

Jan 7, 5:56 PM ET

BUCHEN DAVID A 4

4 · Amneal Pharmaceuticals, Inc. · Filed Jan 7, 2019

Insider Transaction Report

Form 4
Period: 2019-01-03
Amneal Pharmaceuticals, Inc.AMRX
BUCHEN DAVID A
SVP, Chief Legal Officer
Transactions
  • Award

    Stock Option

    2019-01-03+227,273→ 227,273 total
    Exercise: $13.58Exp: 2029-01-03→ Class A Common Stock (227,273 underlying)
  • Award

    Restricted Stock Units

    2019-01-03+110,457→ 110,457 total
    → Class A Common Stock (110,457 underlying)
Footnotes (3)
  • [F1]The option vests in four equal annual installments beginning on January 3, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning on January 3, 2020 and have no expiration date.

Documents

1 file
  • 4
    wf-form4_154690177391907.xmlPrimary

    FORM 4